Leading pharmaceutical giant, Abbvie Inc (ABBV), is now on my trading radar for a potential longside trade. Abbvie stock topped out on July 17th, 2020 at $101.28 a share. Since that pivot high, the shares have steadily declined and now trade around the $88.00 area. The pharma giant has been pulling back for nearly 3 months, working off a very overbought condition on the larger time-frame charts.
The next major support level for Abbvie stock will be around the $82.00 level. This is where there is a major retrace level in the stock from the March 2020 lows to the July 2020 top. It is also a support area where the stock broke out in early May 2020. Often, prior break-out levels will serve as excellent support when initially tested. I will be waiting to see how Abbvie stock trades into this important support area for a buying opportunity. Please remember, ABBV stock will report earnings on October 30th, 2020 before the opening bell.
(Click on image to enlarge)





Comments
Log in or sign up to join the conversation.